Issued Patents All Time
Showing 1–25 of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12331328 | CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndrome | Eric A. Pierce, Carrie Marie Margulies, Nachiket D. Pendse, Sebastian W. Gloskowski, Qin Liu | 2025-06-17 |
| 12234449 | CRISPR/Cas-related methods and compositions for treating Leber's congenital amaurosis 10 (LCA10) | David Bumcrot, Shen Shen | 2025-02-25 |
| 12152254 | TAL-Tet1 fusion proteins and methods of use thereof | J. Keith Joung, James Angstman | 2024-11-26 |
| 12065668 | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci | J. Keith Joung | 2024-08-20 |
| 11806408 | Methods and compositions for treating cone-rod retinal dystrophy | Shannon E. Boye, Sanford L. Boye | 2023-11-07 |
| 11634731 | Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing | J. Keith Joung, Jeffry D. Sander, Yanfang Fu | 2023-04-25 |
| 11566263 | Compositions and methods for treating CEP290 associated disease | Rina J. MEPANI, Michael Stefanidakis | 2023-01-31 |
| 11339437 | Compositions and methods for treating CEP290-associated disease | Rina J. MEPANI, David Bumcrot, Shen Shen, Michael Stefanidakis | 2022-05-24 |
| 11268086 | CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10) | David Bumcrot, Shen Shen | 2022-03-08 |
| 11242525 | CRISPR/CAS-related methods and compositions for treating sickle cell disease | Ari E. Friedland, G. Grant Welstead, David Bumcrot | 2022-02-08 |
| 11168338 | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci | J. Keith Joung | 2021-11-09 |
| 11141493 | Compositions and methods for treating CEP290-associated disease | Rina J. MEPANI, David Bumcrot, Shen Shen, Michael Stefanidakis | 2021-10-12 |
| 11028388 | CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa | David Bumcrot | 2021-06-08 |
| 11028394 | CRISPR/CAS-related methods and compositions for treating cystic fibrosis | Deepak Reyon, Ari E. Friedland, G. Grant Welstead, David Bumcrot | 2021-06-08 |
| 10894950 | TAL-Tet1 fusion proteins and methods of use thereof | J. Keith Joung, James Angstman | 2021-01-19 |
| 10844403 | Increasing specificity for RNA-guided genome editing | J. Keith Joung, James Angstman, Jeffry D. Sander, Shengdar Tsai | 2020-11-24 |
| 10760064 | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci | J. Keith Joung | 2020-09-01 |
| 10731167 | Tale transcriptional activators | J. Keith Joung | 2020-08-04 |
| 10676749 | Tale transcriptional activators | J. Keith Joung | 2020-06-09 |
| 10415059 | Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing | J. Keith Joung, Jeffry D. Sander, Yanfang Fu | 2019-09-17 |
| 10378027 | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci | J. Keith Joung | 2019-08-13 |
| 10253312 | CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10) | David Bumcrot, Shen Shen | 2019-04-09 |
| 10119133 | Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing | J. Keith Joung, Jeffry D. Sander, Yan Fu | 2018-11-06 |
| 9938521 | CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (LCA10) | David Bumcrot, Shen Shen | 2018-04-10 |
| 9890364 | TAL-Tet1 fusion proteins and methods of use thereof | J. Keith Joung, James Angstman | 2018-02-13 |